期刊文献+

A follow-up study on features of sensory gating P50 in treatment-resistant depression patients 被引量:10

A follow-up study on features of sensory gating P50 in treatment-resistant depression patients
原文传递
导出
摘要 Background Depressive disorder is a well-known chronic, recurrent and disabling mental disease with high direct and indirect costs to society in both western and eastern cultures. Approximately 40% of depressed patients show only partial or no response to initial or even multiple antidepressant medications and are usually called treatment-resistant depression (TRD) patients. The present work was to measure the features of sensory gating (SG) P50 in TRD patients with the intent of understanding the characteristics of this disease. Methods In 50 TRD patients, 39 non-treatment-resistant depression (NTRD) patients and 51 healthy controls (HC), auditory evoked potential P50 was measured using the conditioning/testing paradigm presented with auditory double clicks stimuli, and 36 TRD patients had repeated measurements after an 8-week venlafaxine treatment course. Results All the depressive disorder patients, including the TRD and NTRD groups, showed an increased testing stimulus wave ($2-P50) amplitude compared to controls (P 〈0.01 and P 〈0.05), but there was no significant difference between the TRD and NTRD groups (P 〉0.05). There were significant differences in the ratio of testing stimulus (S2) and conditioning stimulus (S1) (S2/S1) and in the value of 100 × (1-S2/S1) among the three groups. Compared to the baseline, TRD patients had no significant changes of features and different expression of P50 after acute treatment (P 〉0.05). Meanwhile, a statistically significant positive correlation of S2/S1 with the scores of the 17-item Hamilton Rating Scale for Depression (HAMD-17) (P 〈0.01), and a significantly negative correlation of S1-S2, 100 × (1-S2/S1) with the scores of HAMD-17 (P 〈0.01) were observed in the TRD patients' baseline measurement, but there was no correlation after venlafaxine treatment (P 〉0.05). Conclusions Both the TRD and NTRD patients had obvious SG deficits, with a more severe deficit in TRD patients. Although, with a correlated relationship to the severity of depressive symptoms, SG P50 deficit might be suggested as a trait marker for TRD, and a combination of S2/S1 ratio, S1-S2 and 100 × (1-S2/S1), was recommended for electrophysiological measurement in TRD patients. Background Depressive disorder is a well-known chronic, recurrent and disabling mental disease with high direct and indirect costs to society in both western and eastern cultures. Approximately 40% of depressed patients show only partial or no response to initial or even multiple antidepressant medications and are usually called treatment-resistant depression (TRD) patients. The present work was to measure the features of sensory gating (SG) P50 in TRD patients with the intent of understanding the characteristics of this disease. Methods In 50 TRD patients, 39 non-treatment-resistant depression (NTRD) patients and 51 healthy controls (HC), auditory evoked potential P50 was measured using the conditioning/testing paradigm presented with auditory double clicks stimuli, and 36 TRD patients had repeated measurements after an 8-week venlafaxine treatment course. Results All the depressive disorder patients, including the TRD and NTRD groups, showed an increased testing stimulus wave ($2-P50) amplitude compared to controls (P 〈0.01 and P 〈0.05), but there was no significant difference between the TRD and NTRD groups (P 〉0.05). There were significant differences in the ratio of testing stimulus (S2) and conditioning stimulus (S1) (S2/S1) and in the value of 100 × (1-S2/S1) among the three groups. Compared to the baseline, TRD patients had no significant changes of features and different expression of P50 after acute treatment (P 〉0.05). Meanwhile, a statistically significant positive correlation of S2/S1 with the scores of the 17-item Hamilton Rating Scale for Depression (HAMD-17) (P 〈0.01), and a significantly negative correlation of S1-S2, 100 × (1-S2/S1) with the scores of HAMD-17 (P 〈0.01) were observed in the TRD patients' baseline measurement, but there was no correlation after venlafaxine treatment (P 〉0.05). Conclusions Both the TRD and NTRD patients had obvious SG deficits, with a more severe deficit in TRD patients. Although, with a correlated relationship to the severity of depressive symptoms, SG P50 deficit might be suggested as a trait marker for TRD, and a combination of S2/S1 ratio, S1-S2 and 100 × (1-S2/S1), was recommended for electrophysiological measurement in TRD patients.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第24期2956-2960,共5页 中华医学杂志(英文版)
关键词 treatment-resistant depression sensory gating evoked potentials auditory biological markers treatment-resistant depression sensory gating evoked potentials, auditory biological markers
作者简介 Correspondence to: Dr. FANG Yi-ru, Division of Mood disorder, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China (Tel: 86-21-34289888-3529. Fax: 86-21-54255870. Email: yirufang@ yahoo.com.cn);Dr. CHEN Xing-shi, Department of Electrophysiology, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China (Tel: 86-21-34289888-3324. Email: chenxingshi2008@ 163.com)
  • 相关文献

参考文献2

二级参考文献22

  • 1苏晖,江开达,徐一峰,宋立升,虞一萍.抑郁症首次发病患者认知功能的研究[J].中华精神科杂志,2005,38(3):146-149. 被引量:86
  • 2Boutros NN,Belger A.Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating.Biol Psychiatry,1999,45:917-922.
  • 3Oranje B,van Berckel BN,Kemner C,et al.P50 suppression and prepulse inhibition of the startle reflex in humans:a correlational study.Biol Psychiatry,1999,45:883-890.
  • 4Light GA,Geyer MA,Clementz BA,et al.Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.Am J Psychiatry,2000,157:767-771.
  • 5Olincy A,Martin L.Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis.Am J Psychiatry,2005,162:43-49.
  • 6Neu P,Bajbouj M,Schilling A,et al.Cognitive function over the treatment course of depression in middle-aged patients:correlation with brain MRI signal hyperintensities.J Psychiatr Res,2005,39:129-135.
  • 7Mayberg HS,Liotti M,Brannan SK,et al.Reciprocal limbic-cortical function and negative mood:converging PET findings in depression and normal sadness.Am J Psychiatry,1999,156:675-682.
  • 8Meyer SE,Carlson GA,Wiggs EA,et al.A prospective study of the association among impaired executive functioning,childhood attentional problems,and the development of bipolar disorder.Dev Psychopathol,2004,16:461-476.
  • 9Thoma RJ,Hanlon FM,Moses SN,et al.M50 sensory gating predicts negative symptoms in schizophrenia.Schizophr Res,2005,73:311-318.
  • 10Braff DL.Psychophysiological and information processing approaches to schizophrenia,in neurobiological foundation of mental illness.In:Charney DS,Nestler E,Bunney BS.New York:Oxford University Press,1999.258-271.

共引文献28

同被引文献68

引证文献10

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部